The lab uses a very broad array of techniques including molecular and cellular biology, state-of-the-art imaging, flow cytometry, bioinformatics, structural biology and bioengineering approaches to understand the human antibody response to major pathogens. Current studies center on Influenza, Zika, Ebola, Marburg, respiratory syncytial virus, and numerous other emerging pathogens. In addition to understanding the immunology of the response, we are dedicated to harnessing this response as a source of antibodies for protective and therapeutic applications. We are particularly interested in rapid antibody discovery methods where this human antibody-centered discovery platform can empower real-time pandemic medical countermeasure development.

>> View Publications on PubMed